A Case of Atypical Pneumonia Due to Severe COVID-19 and Cross Reaction with Coxiella burnetii
DOI:
https://doi.org/10.20344/amp.18668Keywords:
COVID-19, Coxiella burnetii, Cross Reactions, Pandemics, Portugal, Q Fever, SARS-CoV-2 InfectionAbstract
N/a.
Downloads
References
World Health Organization. Timeline: WHO’s COVID-19 response. [consultado 2022 maio 05] Disponivel em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline#!.
Direção-Geral da Saúde. Orientação nº 02A/2020 de 25/01/2020 atualizada em 25/02/2020. Doença pelo novo coronavírus (COVID-19) – nova definição de caso. Lisboa: DGS; 2021.
Park HS, Bae PK. Serological evidence of coxiella burnetii and SARSCoV-2 co-infection: a case report. Ann Lab Med. 2021;41:510-3.
Gillot C, Douxfils J, Cadrobbi J, Laffineur K, Dogné JM, Elsen M. Anoriginal ELISA-based multiplex method for the simultaneous detection of 5 SARS-CoV-2 IgG antibodies directed against different antigens. J Clin Med. 2020;9:3752.
Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2020;19:171-83.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.